Andrew Radonjic – Managing Director – Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Copyright 2024 – Finance News Network
06 Jul 2023 - Tamboran Resources Limited (ASX:TBN) Managing Director and CEO Joel Riddle discusses the company's recent capital raise, the drilling timeline, and agreements with APA Group, Clean Energy Fuels Australia, BP and Shell.
10 Mar 2020 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack, provides an update on the company's key lithium petalite project in Zimbabwe.
27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
27 May 2022 - TerraCom Limited (ASX:TER) Executive Chairman Craig Ransley discusses drivers behind the company's performance and share price over the previous year.
29 Nov 2023 - Equinox Resources Limited (ASX:EQN) CEO Zac Komur discusses the company's move to apply for a large rare earths tenement in Brazil, and the attractions of the jurisdiction.
16 Aug 2023 - Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
01 Apr 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari introduces the company, discussing the use of radiopharmaceuticals for cancer treatment and the company's upcoming trial in non-small cell lung cancer.